Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Guangping He

Obstetrics & Gynecology Hospital of Fudan University, 128 Shenyang Road, Shanghai, 200433, China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 22, 2026 · JOURNAL ARTICLE

Harnessing necroptosis via RIPK1 degradation to potentiate radio-immunotherapy in cervical cancer.

Bioactive Materials

Preclinical mechanistic study in cell and animal models demonstrating a potential strategy; no clinical trial data, human efficacy evidence, or comparison to standard care reported.

Hypothesis-GeneratingGuangping He Yuandong Fu Bin Lv

Reported

Cytokine production increasenearly doubled

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support